BCM-HGSC eMERGE

eMERGE HGSC-Clinical Laboratory

The Electronic Medical Records and Genomics (eMERGE) Phase III program of the National Institutes of Health aims to develop and validate electronic phenotyping algorithms for large-scale, high-throughput genomics research; to discover genetic variants related to complex traits; to disseminate results and lessons learned to the scientific community; and to deliver state-of-the-art genomic knowledge, methods, and approaches to clinical decision support and clinical care.

eMERGE III consists of nine study sites, two central sequencing and genotyping facilities and a coordinating center. This portal is for sample uploads from sites served by the Human Genome Sequencing Center-Clinical Laboratory (HGSC-CL) and serves as a gateway to all data housed in the eMERGE Data Commons.

Investigators at external institutions may apply for affiliate membership to the eMERGE Network. Information about affiliate membership such as benefits, criteria for participation, and application process can be found at the eMERGE webpage.


eMERGE News

  August 31, 2017

An upcoming scheduled maintenance window is starting Tuesday, September 5th and ending Wednesday, September 6th. During this time, the RD Discover, SD Discover, Subject Locator and Record Counter applications will be unavailable for use. Our RD/SD database will also be unavailable.

  June 22, 2017

CMS announced last week it will award up to $30 million in grant funding to clinical specialty societies, clinical professional organizations and independent research organizations to develop quality measures under the Medicare Access and Children’s Health Insurance Program Reauthorization Act of 2015 (MACRA). This was among AMIA’s top...

  February 10, 2017

eMERGE is excited to share the results of the national multi-site survey it conducted to investigate public attitudes towards consent and data sharing in biobank research recently publish in AJHG.  For the full article click here